CRESCENT BIOPHARMA, INC.
Ticker: 1253689
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q2 FY2022 | Q2 FY2022 | Q3 FY2021 | Q3 FY2021 | Q2 FY2021 | Q1 FY2021 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 1.04+1200.0% | 0.08+0.0% | 0.08-11.1% | 0.09+0.0% | 0.09 | 0.00-100.0% | 1.06 |
| Total Income | 1.04+1200.0% | 0.08+0.0% | 0.08-11.1% | 0.09+0.0% | 0.09 | 0.00-100.0% | 1.06 |
| EXPENSES | |||||||
| Expenditure | 25.77+91.9% | 13.43+0.0% | 13.43-22.9% | 17.42+0.0% | 17.42+21.0% | 14.40-6.1% | 15.34 |
| Tax | 0.00 | — | — | — | — | — | — |
| PROFIT | |||||||
| Net Profit | -23.28-75.4% | -13.27+0.0% | -13.27+23.4% | -17.33+0.0% | -17.33-20.3% | -14.40-0.9% | -14.27 |
| KEY METRICS | |||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | — | -0.25+0.0% | -0.25 | — | -0.34 | — | -0.28 |
Corporate Events
Board MeetingCBIO
20262Jun
Board Meeting
Annual General Meeting of Shareholders to elect two Class II…
SEC Filing ↗